Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 2/3 1Phase 2 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Fatigue 7Neoplasms 4Brain Neoplasms 3Depression 2Asthenia 2Recurrence 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Neoplasm Metastasis 1Meningioma 1Gliosarcoma 1Glioma, Subependymal 1Glioma 1Glioblastoma 1Gastrointestinal Neoplasms 1Ependymoma 1Central Nervous System Neoplasms 1Breast Neoplasms 1Astrocytoma 1

Interventions

Psychiatric Rehabilitation 2Methylphenidate 2Vortioxetine 1Vitamin E 1Therapeutics 1Sertraline 1Radiotherapy 1Pharmacogenomic Testing 1Mindfulness 1Ketamine 1Hypericum extract LI 160 1Escitalopram 1Duloxetine Hydrochloride 1Donepezil 1Dehydroepiandrosterone 1Counseling 1Carnitine 1Analgesia 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Depression × Methylphenidate × Clear all
NCT00031798 2021-09-09

Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors

Wake Forest University Health Sciences

Phase 3 Terminated
CNSSarcoma

Astrocytoma, Brain Neoplasms, Depression, Ependymoma, Fatigue, Glioblastoma, Glioma, Meningioma, Oligodendroglioma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Glioma, Subependymal, Gliosarcoma

NCT01497548 2011-12-22

Study of Methylphenidate as Add on Therapy in Depressed Cancer Patients

University of Malaya

Phase 3 Unknown
120 enrolled

Depression, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡